Medical Equipment

The Drug Infusion Systems Market Is Witnessing Impact From Rising Healthcare Expenditure Drives Growth In The Drug Infusion Systems Market

April 10, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Drug Infusion Systems Market From 2026 To 2030?

The drug infusion systems market size has experienced significant expansion recently. Projections indicate that this market will expand from $14.23 billion in 2025 to $15.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.0%. Historically, this expansion has been driven by factors such as escalating hospitalization rates, an increasing occurrence of chronic diseases, the broadening of oncology and chemotherapy treatments, a greater adoption of intravenous drug delivery methods, and enhanced access to infusion technologies.

The drug infusion systems market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $22.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This projected growth during the forecast period can be linked to several factors, including the wider acceptance of connected infusion systems, an escalating need for ambulatory and homecare infusion options, the proliferation of precision drug delivery methods, a heightened emphasis on automating hospital workflows, and greater capital expenditure on intelligent healthcare infrastructure. Key developments expected in this period encompass the growing popularity of smart infusion pumps, the increasing incorporation of dose error reduction systems, the expanded deployment of multi-channel infusion devices, the wider availability of home-based infusion treatments, and a stronger emphasis on characteristics that ensure patient safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

Which Strong Drivers Are Impacting The Drug Infusion Systems Market Growth?

The drug infusion systems market is anticipated to experience growth driven by increasing healthcare expenditure. This refers to the total amount of money spent on healthcare goods and services within a specific timeframe, usually a year. As healthcare expenditures rise, hospitals, clinics, and other medical institutions acquire greater financial capacity to invest in advanced drug infusion systems, consequently stimulating demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a national statistical institute located in the UK, indicated that total healthcare spending saw a nominal increase of 5.6% from 2022 to 2023, which is a considerable jump from the 0.9% growth rate observed in 2022. Therefore, the upward trend in healthcare expenditure is set to propel the expansion of the drug infusion systems market.

How Are Segments Identified Within The Drug Infusion Systems Market Segment Framework?

The drug infusion systems market covered in this report is segmented –

1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

Subsegments:

1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

Which Trends Are Contributing To Changes In The Drug Infusion Systems Market?

Prominent companies in the drug infusion systems market are innovating with advanced technology, such as cloud-based infusion management systems, to elevate patient care, enhance accuracy, and optimize the handling of infusion therapies. Cloud-based infusion management systems serve as digital platforms that enable the monitoring, delivery, and tracking of medication infusions through cloud technology. As an illustration, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a novel cloud-based infusion management system tailored for the specific demands of home and specialty infusions. Eitan Insights is designed to furnish healthcare professionals with real-time data and analytics, empowering them to oversee patients remotely and modify treatment plans as necessary. This system bolsters medication safety by lessening the chance of errors and improving compliance with prescribed protocols.

Who Are The Companies Competing Within The Drug Infusion Systems Market?

Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited

Get The Full Drug Infusion Systems Market Report:

https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

Which Region Leads The Drug Infusion Systems Market In Overall Market Size?

North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug Infusion Systems Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2026, By The Business Research Company

Infusion Pump Market Report 2026

https://www.thebusinessresearchcompany.com/report/infusion-pump-global-market-report

Intravenous Infusion Pumps Market Report 2026

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Perfusion Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/perfusion-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795